During the past decade, Leids Universitair Medisch Centrum/ Klinische Oncologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Leids Universitair Medisch Centrum/ Klinische Oncologie" are "GIST" (1 trials) and "Liposarcoma, Dedifferentiated" (1 trials). Many other conditions were trialed in "Leids Universitair Medisch Centrum/ Klinische Oncologie" in a lesser frequency.

Most popular intervention types in "Leids Universitair Medisch Centrum/ Klinische Oncologie" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BI 907828" (1 trials), "Doxorubicin" (1 trials) and "non-interventional" (1 trials). Other intervention names were less common.

The vast majority of trials in "Leids Universitair Medisch Centrum/ Klinische Oncologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Leids Universitair Medisch Centrum/ Klinische Oncologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Leids Universitair Medisch Centrum/ Klinische Oncologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Leids Universitair Medisch Centrum/ Klinische Oncologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".